Ambit Biosciences Canada (Toronto, On)

CMDF Investment: $6,082,000.00
Focus: Cancer   Central Nervous System Disorders   Inflammatory Diseases  
www.ambitbio.com

Ambit Biosciences is a privately-held biopharmaceutical company that uses groundbreaking technology to discover and develop proprietary small molecule drugs for a variety of clinical indications. Our lead drug candidates include neuroprotectants for treatment of stroke and other CNS disorders and kinase inhibitors for treatment of cancer and inflammatory diseases.